Literature DB >> 15221015

Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).

Akiyoshi Komuro1, Takeshi Imamura, Masao Saitoh, Yoko Yoshida, Takao Yamori, Kohei Miyazono, Keiji Miyazawa.   

Abstract

Smad7 negatively regulates transforming growth factor (TGF)-beta superfamily signaling by binding to activated type I receptors, thereby preventing the phosphorylation of receptor-regulated Smads (R-Smads), as well as by recruiting HECT-type E3 ubiquitin ligases to degrade type I receptors through a ubiquitin-dependent mechanism. To elucidate the regulatory mechanisms of TGF-beta signaling, we searched for novel members of proteins that interact with Smad7 using a yeast two-hybrid system. One of the proteins identified was the WW domain-containing protein 1 (WWP1) that is structurally related to Smad ubiquitin regulatory factors (Smurfs), E3 ubiquitin ligases for Smads and TGF-beta superfamily receptors. Using a TGF-beta-responsive reporter in mammalian cells, we found that WWP1 inhibited transcriptional activities induced by TGF-beta. Similar to Smurfs, WWP1 associated with Smad7 and induced its nuclear export, and enhanced binding of Smad7 to TGF-beta type I receptor to cause ubiquitination and degradation of the receptor. Consistent with these results, WWP1 inhibited phosphorylation of Smad2 induced by TGF-beta. WWP1 thus negatively regulates TGF-beta signaling in cooperation with Smad7. However, unlike Smurfs, WWP1 failed to ubiquitinate R-Smads and SnoN. Importantly, WWP1 and Smurfs were expressed in distinct patterns in human tissues and carcinoma cell lines, suggesting unique pathophysiological roles of WWP1 and Smurfs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221015     DOI: 10.1038/sj.onc.1207885

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  72 in total

1.  The ubiquitin E3 ligase WWP1 decreases CXCL12-mediated MDA231 breast cancer cell migration and bone metastasis.

Authors:  Kristina Subik; Lei Shu; Chengyu Wu; Qianqian Liang; David Hicks; Brendan Boyce; Linda Schiffhauer; Di Chen; Ceshi Chen; Ping Tang; Lianping Xing
Journal:  Bone       Date:  2012-01-11       Impact factor: 4.398

2.  Smad7 restricts melanoma invasion by restoring N-cadherin expression and establishing heterotypic cell-cell interactions in vivo.

Authors:  Kyle A DiVito; Valerie A Trabosh; You-Shin Chen; Yu Chen; Chris Albanese; Delphine Javelaud; Alain Mauviel; Cynthia M Simbulan-Rosenthal; Dean S Rosenthal
Journal:  Pigment Cell Melanoma Res       Date:  2010-08-25       Impact factor: 4.693

3.  Smad7 inhibits transforming growth factor-beta family type i receptors through two distinct modes of interaction.

Authors:  Yuto Kamiya; Kohei Miyazono; Keiji Miyazawa
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

4.  Rare copy number variants disrupt genes regulating vascular smooth muscle cell adhesion and contractility in sporadic thoracic aortic aneurysms and dissections.

Authors:  Siddharth K Prakash; Scott A LeMaire; Dong-Chuan Guo; Ludivine Russell; Ellen S Regalado; Hossein Golabbakhsh; Ralph J Johnson; Hazim J Safi; Anthony L Estrera; Joseph S Coselli; Molly S Bray; Suzanne M Leal; Dianna M Milewicz; John W Belmont
Journal:  Am J Hum Genet       Date:  2010-11-18       Impact factor: 11.025

5.  Wwp2-mediated ubiquitination of the RNA polymerase II large subunit in mouse embryonic pluripotent stem cells.

Authors:  Hui Li; Zhihong Zhang; Beibei Wang; Junmei Zhang; Yingming Zhao; Ying Jin
Journal:  Mol Cell Biol       Date:  2007-05-25       Impact factor: 4.272

6.  Cardiomyocyte-specific overexpression of the ubiquitin ligase Wwp1 contributes to reduction in Connexin 43 and arrhythmogenesis.

Authors:  Wassim A Basheer; Brett S Harris; Heather L Mentrup; Measho Abreha; Elizabeth L Thames; Jessica B Lea; Deborah A Swing; Neal G Copeland; Nancy A Jenkins; Robert L Price; Lydia E Matesic
Journal:  J Mol Cell Cardiol       Date:  2015-09-16       Impact factor: 5.000

7.  Fine-tuning BMP7 signalling in adipogenesis by UBE2O/E2-230K-mediated monoubiquitination of SMAD6.

Authors:  Xiaofei Zhang; Juan Zhang; Andreas Bauer; Long Zhang; Douglas W Selinger; Chris X Lu; Peter Ten Dijke
Journal:  EMBO J       Date:  2013-03-01       Impact factor: 11.598

Review 8.  SMAD7: a timer of tumor progression targeting TGF-β signaling.

Authors:  Lingyu Luo; Nianshuang Li; Nonghua Lv; Deqiang Huang
Journal:  Tumour Biol       Date:  2014-06-17

Review 9.  To (TGF)beta or not to (TGF)beta: fine-tuning of Smad signaling via post-translational modifications.

Authors:  Katharine H Wrighton; Xin-Hua Feng
Journal:  Cell Signal       Date:  2008-02-15       Impact factor: 4.315

10.  Functional Characterization of a WWP1/Tiul1 Tumor-derived Mutant Reveals a Paradigm of Its Constitutive Activation in Human Cancer.

Authors:  Thomas Courivaud; Nathalie Ferrand; Abdelouahid Elkhattouti; Santosh Kumar; Laurence Levy; Olivier Ferrigno; Azeddine Atfi; Céline Prunier
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.